India s Ambassador to the US, Taranjit Singh Sandhu, visited the city of Philadelphia during which he interacted with some of the top pharmaceutical companies and had a meeting with the city mayor, who applauded India for supplying with two million N-95 masks last year. A pleasure to start the day in Philadelphia with a meeting with Philadelphia Mayor Jim F Kenney, Sandhu said in a tweet as he kicked off his two-day trip to the city on June 11. This was his first travel out of the national capital area during the COVID-19 crisis. During the meeting, Kenney thanked India for supplying two million N-95 masks to Philadelphia in 2020, Sandhu said.
The key barometers hovered near the flat line in early afternoon trade. Metal shares tumbled while autos and FMCG shares bucked weak market trend.
At 12:20 IST, the barometer index, the S&P BSE Sensex, rose 6.05 points or 0.01% at 51,943.49. The Nifty 50 index lost 15.25 points or 0.10% at 15,567.55. The Nifty pared losses after hitting the day s low of 15,528.30 in early afternoon trade.
In the broader market, the S&P BSE Mid-Cap index fell 0.39% while the S&P BSE Small-Cap index slipped 0.51%.
The market breadth was weak. On the BSE, 1,112 shares rose and 1,857 shares fell. A total of 124 shares were unchanged.
Derivatives:
The NSE s India VIX, a gauge of market s expectation of volatility over the near term, jumped 5.92% to 17.89. The Nifty 29 July 2021 futures were trading at 15,564.45, at a discount of 3.10 points as compared with the spot at 15,567.55.
Read more about Jubilant Pharmova subsidiary to invest $92 mln for expansion on Business Standard. Jubilant Pharma, a wholly-owned subsidiary of Jubilant Pharmova, announced $92 million investment plans to expand sterile injectable manufacturing capacity at its Spokane site in Washington, US.
Remdesivir output jumps 10 times, govt halts central allocation to states
By IANS |
0 Views
Remdesivir output jumps 10 times, govt halts central allocation to states. Image Source: IANS News
New Delhi, May 29 : As the production of Remdesivir was ramped up ten times from 33,000 vials per day to 3.5 lakh, the Central government on Saturday decided to discontinue the central allocation of Remdesivir vials to states.
Minister of State for Chemicals and Fertilisers, Mansukh Mandaviya, made the announcement and also directed the National Pharmaceuticals Pricing Agency and Central Drugs Standard Control Organisation (CDSCO) to continuously monitor the availability of Remdesivir in the country.
The Minister informed that the production of Remdesivir was ramped up ten times from 33,000 vials per day on April 11 this year to 3,50,000 vials per day on Saturday.